Hundreds of industry leaders have signed a letter to FDA director Marty Makary, M.D., about the importance of having a ...

Roche has claimed the exclusive international rights to Freenome’s multiomic cancer screening approaches, toward the goal of ...

The Fierce team will be out of office next Friday for the Thanksgiving holiday. The next edition of Chutes & Ladders will ...

The CDC is instructing scientists to end all research involving monkeys by the end of the year, in a move that will ...

The FDA says it is hiring more than 1,000 new employees and rolling out a pilot communication program in efforts to speed up ...

Nurix Therapeutics is trimming its workforce not long after launching a pivotal phase 2 trial for its lead cancer asset. | ...

With much of Moderna’s recent rise tied to its COVID-19 vaccine, the company has struggled to match the sales highs it ...

GE HealthCare plans to pay $2.3 billion in cash to acquire imaging software developer Intelerad, toward the goal of building ...

Aspen Neuroscience’s cash reserves have been fertilized with a $115 million series C fundraise that will enrich the biotech’s ...

GSK has picked a novel protein biotech and a genomics biotech as its first collaborators under a $7 billion biobucks deal ...

In January, Exact Sciences CEO Kevin Conroy told us that 2025 was shaping up to be a transformative year for the diagnostics ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...